Table 3.
Case groups |
|||||
---|---|---|---|---|---|
Controls (n=2368) | All cases (n=592) | IHD (n=194) | COPD (n=182) | Asthma (n=216) | |
Phase 1 (code alone) | |||||
n (%) | |||||
Without breathlessness or wheeze code | 2227 (94) | 414 (70) | 155 (80) | 111 (61) | 148 (69) |
With breathlessness or wheeze code | 141 (6) | 178 (30) | 39 (20) | 71 (39) | 68 (31) |
RRR (95% CI), age and gender adjusted | |||||
With vs without breathlessness or wheeze code | 1.00 | 7.02 (5.48 to 9.00) | 3.21 (2.15 to 4.79) | 9.56 (6.74 to 13.60) | 10.30 (7.17 to 14.90) |
Phase 2 (code or textual information) | |||||
n (%) | |||||
Without breathlessness/wheeze code or text | 1776 (75) | 224 (38) | 95 (49) | 57 (31) | 72 (33) |
With breathlessness/wheeze code or text | 592 (25) | 368 (62) | 99 (51) | 125 (69) | 144 (67) |
RRR (95% CI), age and gender adjusted | |||||
With vs without breathlessness/wheeze code or text | 1.00 | 5.14 (4.24 to 6.25) | 2.78 (2.05 to 3.78) | 6.32 (4.54 to 8.80) | 7.86 (5.73 to 10.80) |
COPD, chronic obstructive airways disease; IHD, ischaemic heart disease; RRR, relative risk ratios.